Voyageur Pharmaceuticals (CVE:VM) Stock Price Down 11.5% – Here’s Why

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report) dropped 11.5% on Saturday . The stock traded as low as C$0.27 and last traded at C$0.27. Approximately 407,425 shares traded hands during mid-day trading, an increase of 105% from the average daily volume of 198,342 shares. The stock had previously closed at C$0.31.

Voyageur Pharmaceuticals Trading Down 11.5%

The stock has a market capitalization of C$40.91 million, a P/E ratio of -25.25 and a beta of 0.32. The stock has a 50-day moving average price of C$0.20 and a two-hundred day moving average price of C$0.17. The company has a debt-to-equity ratio of 4.23, a quick ratio of 0.84 and a current ratio of 0.10.

About Voyageur Pharmaceuticals

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Featured Stories

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.